Analystreport

Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its price target raised by analysts at HC Wainwright from $6.00 to $20.00.

Syros Pharmaceuticals, Inc.  (SYRS) 
Last syros pharmaceuticals, inc. earnings: 3/5 06:57 am Check Earnings Report
US:NASDAQ Investor Relations: ir.syros.com